Connect with us

Health

First COVID-19 vaccine doses to arrive in Thailand later this month

The Prime Minister and the Minister of Defence Gen Prayut Chan-o-cha has confirmed the first 200,000 doses of COVID-19 vaccine from China’s Sinovac will be arrival in Thailand in late-February.

National News Bureau of Thailand

Published

on

BANGKOK (NNT) – The Prime Minister has confirmed the first 200,000 doses of COVID-19 vaccine will be arriving in Thailand, with first jabs performed 3 days after arrival.

Loading...

The Prime Minister and the Minister of Defence Gen Prayut Chan-o-cha has confirmed the first 200,000 doses of COVID-19 vaccine from China’s Sinovac will be arrival in Thailand in late-February.

After the arrival in the country, health officials will take 3 more days to make preparations for the first administration of this vaccine to the Thai people. The vaccines will be distributed to different population based on a set priority, with instructions from manufactures suggesting appropriate age group for different types of vaccine.

Following the first lot, 800,000 more doses of Sinovac’s COVID-19 vaccine will be arriving in the second lot, followed by 1 million doses in the third lot.

These doses will be administrated as the second shot for the first groups of people who have received the first shot, and the next groups of people carrying infection risks. Other factors such as occupation as manual workers and residency in tourism areas.

The Prime Minister said the first 26 million doses of Astra Zeneca’s vaccine will be arriving in Thailand in approximately May or June, followed by another 35 million doses on a later date. Once they are arrived, health officials can start making the vaccination plan to promote continuity and conformity.

On the registration of COVID-19 vaccines, the Food and Drugs Administration has officially registered AstraZeneca’s vaccine for emergency use in Thailand, with the registration for Sinovac’s vaccine to be completed before the arrival of the first doses. Currently, Johnson & Johnson is now processing the registration with the FDA, while talks are being made for the Moderna and Pfizer without any documents sent yet to the FDA.

Comments

Companies

AstraZeneca Approves Thailand’s Vaccine Factory

National News Bureau of Thailand

Published

on

BANGKOK (NNT) – AstraZeneca has approved safety standards at Thailand’s vaccine factory and will send the first batch of raw materials for vaccine production in June.

Loading...
(more…)

Continue Reading

Health

Skin-lightening products market to reach US$31 billion by 2024

In emerging Asian and African economies, the natural aspiration to enhance one’s circumstances has led to rapid growth in the market for skin-lightening products, which is projected to reach US$31 billion by 2024.

Avatar

Published

on

Recent years have seen evolving awareness of systemic inequities including racism, sexism and pro-Western chauvinism.

Loading...
(more…)

Continue Reading

Ecommerce

Has Covid-19 prompted the Belt and Road Initiative to go green?

Oxford Business Group

Published

on

Has Covid-19 prompted the Belt and Road Initiative to go green?
– Covid-19 led to a slowdown in BRI projects
– Chinese overseas investment dropped off in 2020
– Government remains committed to the wide-ranging infrastructure programme
– Sustainability, health and digital to be the new cornerstones of the initiative 

Loading...

Following a year of coronavirus-related disruptions, China appears to be placing a greater focus on sustainable, digital and health-related projects in its flagship Belt and Road Initiative (BRI).

As OBG outlined in April last year, the onset of Covid-19 prompted questions about the future direction of the BRI.

Launched in 2013, the BRI is an ambitious international initiative that aims to revive ancient Silk Road trade routes through large-scale infrastructure development.

By the start of 2020 some 2951 BRI-linked projects – valued at a total of $3.9trn – were planned or under way across the world.

However, as borders closed and lockdowns were imposed, progress stalled on a number of major BRI infrastructure developments.

In June China’s Ministry of Foreign Affairs announced that 30-40% of BRI projects had been affected by the virus, while a further 20% had been “seriously affected”. Restrictions on the flow of Chinese workers and construction supplies were cited as factors behind project suspensions or slowdowns in Pakistan, Cambodia and Indonesia, among other countries.

Read More

Continue Reading

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 14,079 other subscribers

Latest

Trending